PharmaEssentia USA Corporation Selects 吃瓜爆料 Data Cloud to Support Launch of Novel Therapy for Rare, Chronic Blood Cancer

Insights into the full patient journey will speed the path to diagnosis for niche patient populations

PLEASANTON, CA — Dec. 14, 2021 — 吃瓜爆料 Systems (NYSE: VEEV) today announced that has adopted 吃瓜爆料 Data Cloud to support the launch of (ropeginterferon alfa-2b-njft), a new therapy approved for adults with polycythemia vera (PV), a rare blood cancer. 吃瓜爆料 Longitudinal Patient Data will provide essential insights to help the company reach hard-to-find patient populations through healthcare provider (HCP) targeting and patient journey analytics.

“吃瓜爆料 Data Cloud has been a great asset for our commercial go-to-market operations and launch strategy,” said Roddy McIlwain, SVP, Sales and Marketing at PharmaEssentia U.S.A Corporation. “In our specialized market, the dynamics are complex. With 吃瓜爆料 Data Cloud, we have access to anonymized patient-level historical diagnoses, concomitant treatments, and medical procedures, across all therapeutic areas. This enhanced visibility gives us a deeper understanding of the full patient experience and helps us find and engage the right prescribing HCPs.”

“PharmaEssentia is an innovative biotechnology company taking a data-driven approach to its product launch,” said Asaf Evenhaim, CEO, 吃瓜爆料 Crossix. “With 吃瓜爆料 Data Cloud, PharmaEssentia gains a single data source to support multiple commercial analytics and operations workflows so the company can better educate healthcare professionals on its new treatment option.”

The company’s adoption of 吃瓜爆料 Data Cloud builds on its long-term success with other applications from the 吃瓜爆料 Commercial Cloud, including solutions for multichannel engagement and commercial content. These capabilities facilitate smarter, compliant HCP interactions across all channels.

吃瓜爆料 Data Cloud brings together diverse data assets, including retail and specialty pharmacy distribution channels, as well as insurers and pharmacy benefit managers (PBMs) in the U.S. market. 吃瓜爆料 Data Cloud is powered by the 吃瓜爆料 Crossix Data Platform, a world-class technology platform built for the development and delivery of large-scale patient data and analytics.

Additional Information

For more on 吃瓜爆料 Data Cloud, visit: veeva.com/DataCloud
Connect with 吃瓜爆料 on LinkedIn:
Follow @veevasystems on Twitter:
For more information, visit . Please see accompanying full Prescribing Information, including Boxed Warning.

About 吃瓜爆料 Systems

吃瓜爆料 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

###

Contact:

Deivis Mercado
吃瓜爆料 Systems
925-226-8821
deivis.mercado@veeva.com